KIMBERLY CLOVIS: Open Payments
NPI 1144931536 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,034 in 127 payments from 30 companies in 2025. Trend: 2023 $2,434 · 2024 $8,526 · 2025 $3,034
Food & beverage: $2,924Long term medical supply or device loan: $110
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 13 | $311 |
| Xeris Pharmaceuticals, Inc. | 15 | $307 |
| Lilly USA, LLC | 13 | $290 |
| BETA BIONICS, INC. | 14 | $253 |
| Tandem Diabetes Care, Inc. | 3 | $163 |
| Sequel Med Tech, LLC | 1 | $160 |
| Mannkind Corporation | 10 | $155 |
| Dexcom, Inc. | 2 | $147 |
| Novo Nordisk Inc | 8 | $147 |
| Endo USA, Inc. | 6 | $122 |
Products named: Korlym, MOUNJARO, iLet Bionic Pancreas, RECORLEV, t:slim X2 Insulin Pump with Control-IQ, TWIIST, AFREZZA, Dexcom G6 Transmitter.
Industry payments across VA — which companies pay providers there.
